36.20USD+0.61%Mkt Cap: 1.17B $P/E: 17.571d ago
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system …
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Pricier
1M Perf
Lower
Indicators:|
Key Statistics
Company
Market Cap1.17B $
Enterprise Value1.68B $
Revenue (TTM)796.33M $
Gross Profit463.26M $
Net Income (TTM)62.87M $
Revenue/Share25.06 USD
Last Price36.20 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees423
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS19459J1043
Valuation
P/E (Trailing)17.57
P/E (Forward)4.76
PEG—
EV/EBITDA3.96
EV/Revenue2.11
P/S1.47
P/B3.75
EPS (TTM)2.06
EPS (Forward)7.61
52W Range
29.1932% of range50.79
52W High50.79 USD
52W Low29.19 USD
Profitability
Gross Margin59.35%
Oper. Margin15.96%
EBITDA Margin53.38%
Profit Margin8.05%
ROE20.84%
ROA3.79%
Growth
Revenue Growth8.90%
Earnings Growth-46.60%
Cash Flow & Leverage
Operating CF329.32M $
CapEx (TTM)1.74M $
FCF Margin41.77%
FCF Yield28.33%
Net Debt507.94M $
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity2.70
Current Ratio1.71
Quick Ratio1.50
Book Value/Sh9.641 USD
Cash/Share13.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)54.33 USD
Upside (mean)+50.1%
Target Range45.00 USD – 60.00 USD
$45.00+50.1% to mean$60.00
# Analysts6
Ownership
Shares Out.32.43M
Float32.05M
Insiders1.16%
Institutions127.90%
Short Interest
Short Ratio14.5d
Short % Float19.64%
Short % Out.16.43%
Shares Short5.33M
Short (prev mo.)5.97M
Technical
SMA 5034.16 (+6.0%)
SMA 20039.21 (-7.7%)
Beta0.75
S&P 52W Chg20.05%
Avg Vol (30d)353.13K
Avg Vol (10d)514.23K
Technical Indicators
RSI (14)59.6
MACD0.5006
MACD Signal0.2013
MACD Hist.+0.2993
BB Upper37.10 USD
BB Middle34.14 USD
BB Lower31.18 USD
BB Width17.35%
ATR (14)1.420 USD
Vol Ratio (20d)0.81x